Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07298382 · ClinicalTrials.gov registry record · NA
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
A NA study of Skin, sponsored by Efforia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07298382 is a NA study of Skin that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, above the 47-participant average among 5 other Skin trials with a reported enrollment target (113% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07298382, a NA study of Skin, is actively recruiting participants, sponsored by Efforia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing with deeply nourishing infrared light. This unique protocol is designed to help unlock healthier-looking skin and boost your natural glow.
Conditions Studied
Interventions
- DEVICE Blue Light Therapy
Study Locations (1)
New York
- Efforia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-06 |
| Est. Completion | 2026-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07298382
The ClinicalTrials.gov registry entry for NCT07298382 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 47-participant average among 5 other Skin trials with a reported enrollment target (113% higher). The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin appearing as the primary indexed condition, and to 1 intervention - of which Blue Light Therapy is the first listed.
NCT07298382 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07298382 about?
NCT07298382 is a clinical study titled "See the Impact Beem's Blue Light Therapy Has on Your Skin Health!". Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing wit...
What is the current status of trial NCT07298382?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-06. Estimated completion is 2026-10-06.
What conditions does trial NCT07298382 study?
This clinical trial studies the following conditions: Skin.
What interventions are being tested in trial NCT07298382?
The interventions under investigation include: Blue Light Therapy (DEVICE).
Who is sponsoring clinical trial NCT07298382?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07298382 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumenato Nutritional Supplement on Skin Appearance
COMPLETED · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
COMPLETED · NA
-
Trial of Ixazomib for Kaposi Sarcoma
RECRUITING · Phase 2
-
In Vivo Cross-Modal Imaging of Skin
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.